TOMI Environmental Solutions, Inc.

Good day, ladies and gentlemen, and welcome to the Atomi Environmental Solutions Inc. First Quarter 2021 Financial Results Conference Call. At this time, all participants have been placed on listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Dr. Holden Shane and Nick Jennings, after a brief introduction from John Nesbitt. John, please go ahead.

Good afternoon, and thank you for joining us today for the Tomei Environmental Solutions Investor Update Conference Call. On today's call is Tomei's CEO and Chairman of the Board, Dr. Holden Shane, and Nick Jennings, Tomei's Chief Financial Officer. Dr. Shane will provide an overview of recent business highlights and discuss critical financial benchmarks for the most recent quarter before addressing any questions you may have. The telephone replay of today's call will be available through May 24, 2021, the details of which are included in the company's press release of May 17, 2021. A webcast replay will also be available at Tomi's website, www.tomimist.com. I remind you that during this conference call, we will make certain forward-looking statements, including discussions of the business outlook and financial projections. These forward-looking statements are based on management's current expectations and involve risks and uncertainties that could cause actual results to differ materially from such expectations. For a more detailed description of these risks and uncertainties, please refer to our recent and subsequent filings with the SEC. We assume no obligation to update the information provided in today's call. I will now give the call to TOME CEO and Chairman of the Board, Dr. Holden Shamm. Go ahead.

Thank you and welcome everyone for joining TOME Environmental Solutions first quarter 2021 earning call. For those new institutional and private investors to TOME, our technology was invented under a defense grant in association with DARPA, the U.S. Defense Advanced Research Project Agency. That is a division of the Department of Defense that is responsible for emerging technologies. That is registered with the United States Environmental Protection Agency and uses a low percentage hydrogen peroxide as its only active ingredient to produce a fog composed mostly of hydroxyl radicals, known as ionized hydrogen peroxide, or IHP. Represented by the Sterimis brand of products, IHP produces a germ-killing aerosol that works like a visual non-caustic gas. Sterimis disinfection has been used to fight multiple pandemics, and weaponized chemical threats, including anthrax, Ebola, MERS, COVID, and latest pandemic, coronavirus, SARS-CoV-2. As we update you today, I think we can all agree that it is reassuring to see the progress being made on this pandemic from both a public health and economic standpoint, now that many therapies and vaccines are widely available. As a company that focuses on safety, we are very glad to see things improving. With that being said, our first quarter 2021 performance had a steep comparison to last year's first quarter. When the pandemic was just beginning and Tomi benefited from tremendous increased demand in the marketplace, for disinfection and decontamination solutions. The 2020 pandemic unquestionably brought disinfection worldwide to the forefront and drove a significant sales increase for TOMI because, one, our disinfectant is an EPA-registered mechanical disinfectant, and on the EPA list N for SARS-CoV-2, with a five-second spray and an amazing consistent six-log kill. And two, customers were looking for products that would aid in their ability to keep their businesses open. However, as the quarantine and shutdown gained traction and more and more businesses implemented remote work, we saw a slowdown in demand for our product from these new customers. In addition, many of our existing life science customers also implemented remote work early during the pandemic, which has continued into 2021. Due to the changing work environment, particularly when office and workspaces no longer require disinfection as people are working from home, many customers pause the majority of their capital expenditures related to decontamination and safety solutions TOMI provides. For example, the pharmaceutical industry had to scale down their production to meet COVID guidelines. In terms of capital purchases, this is the group of customers that prefer our environment system and our custom engineered system, our higher price product line. While the economy has begun to reopen, We expect workers will be returning to office, which should increase expenditures for disinfection products. Despite the challenging environment during the first quarter, we made considerable progress advancing key building blocks for our long-term growth, including expanding our internal sales force and continuing development of three exciting new products, which I will provide more detail on in a minute. First, let me turn the call over to Nick Jennings, our CFO, who will quickly run through the numbers.